followers
RT @Transplant_Doc: imatinib (Gleevec) is associated with 40% response rate in chronic graft vs. host disease http://t.co/kONA3IfR
RT @Transplant_Doc: imatinib (Gleevec) is associated with 40% response rate in chronic graft vs. host disease http://t.co/kONA3IfR
RT @JSupportOncol: RT @transplant_doc: imatinib (Gleevec) is associated with 40% response rate in chronic graft vs. host disease http://t.co/Rj7Dmr14
RT @transplant_doc: imatinib (Gleevec) is associated with 40% response rate in chronic graft vs. host disease http://t.co/Rj7Dmr14
imatinib (Gleevec) is associated with 40% response rate in chronic graft vs. host disease http://t.co/kONA3IfR